Abstract
Coherent management of thyroid nodules that grow after being identified as benign will vary depending on their biology. Some are thyroid-stimulating hormone (TSH) regulated, so a dose of levothyroxine that reduces TSH to the lower limits of normal (subsuppression) may prevent or reverse enlargement; others are controlled by poorly understood mechanisms that must be elucidated before effective medical treatment can be designed; a few are autonomous requiring obliteration, and a very few are "missed" malignancies that should be excised.
Original language | English (US) |
---|---|
Pages (from-to) | 637-641 |
Number of pages | 5 |
Journal | Thyroid |
Volume | 13 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2003 |
Externally published | Yes |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology